Subscribe to our Newsletters !!
Hybridoma technology is a unique technique that ha
Bio-aerosols aren’t welcome in any laboratory. T
Belly buttons – also referred to as navels – a
Indegene, a digital-first life sciences commercial
Amidst the number of industries showing interest i
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
Glenmark Pharmaceuticals Ltd announced that its U.S. subsidiary received final approval by the country’s regulator for generic Bisoprolol fumarate and Hydrochlorothiazide tablets to treat high blood pressure.
According to a statement, Glenmark Pharmaceuticals Inc., U.S.A was granted approval for Bisoprolol Fumarate tablets in strengths of 2.5 mg/6.25mg, 5 mg/6.25mg, and 10 mg/6.25 MG.
These generic Ziac tablets are 2.5 mg/6.25mg, 5 mg/6.25mg, and 10 mg/6.25mg, respectively, according to Teva Branded Pharmaceutical Products R&D, Inc.
The company cited IQVIATM sales data from the twelve months ending November 2021 and stated that these Ziac tablets generated approximately $30.3 million in annual sales.
Glenmark stated that its current portfolio includes 172 products authorized for distribution in the U.S. market and 46 abbreviated drug applications pending approval by the USFDA.
